Feider Stephen

Chief Financial Officer

Feider Stephen has filed 12 SEC Form 4 filings (26 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Feider Stephen is listed as Chief Financial Officer at Beta Bionics, Inc. Inside the rolling window, Feider Stephen reported no open-market purchases and 11 open-market sales totaling $1.7M in BBNX. The largest disclosed transaction in the window is a sale of 20,000 BBNX shares on Jan 2, 2026, worth $591K.

Companies traded

Other insiders at BBNX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.7M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BBNXSale$128KSep 3SEC ↗
BBNXSale$87KJul 2SEC ↗
BBNXSale$83KJul 2SEC ↗
BBNXSale$84KJun 3SEC ↗
BBNXSale$18KMar 3SEC ↗
BBNXSale$591KJan 5SEC ↗
BBNXSale$42KDec 4SEC ↗
BBNXSale$108KOct 7SEC ↗
BBNXSale$312KOct 3SEC ↗
BBNXSale$209KSep 9SEC ↗
BBNXSale$2KSep 8SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Feider Stephen made?

Feider Stephen has filed 12 SEC Form 4 filings (26 transaction rows) across 1 company since 2025.

Which companies does Feider Stephen trade?

Feider Stephen has filed SEC Form 4 disclosures for 1 company, including BBNX.

When was Feider Stephen's most recent SEC Form 4 filing?

Feider Stephen's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Feider Stephen's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Feider Stephen is listed as Chief Financial Officer.

What is Feider Stephen's total buy and sell value in the current window?

Inside the rolling retention window, Feider Stephen bought $0 and sold $1.7M based on SEC Form 4 filings.

What was Feider Stephen's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 20,000 BBNX shares on 2026-01-02, worth $591K, per SEC Form 4 filings.